A significant breakthrough in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in many forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research